Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10221274 | The Journal of Arthroplasty | 2018 | 45 Pages |
Abstract
Although most studies included in our analysis excluded patients with a history of prior thromboembolic events, our findings support the lack of evidence of harm from TXA administration in patients undergoing TJA. Moderate evidence supports the safety of TXA in patients undergoing total knee arthroplasty with an ASA score of 3 or greater. The benefits of using TXA appear to outweigh the potential risks of thromboembolic events even in patients with a higher comorbidity.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Yale A. MD, Dipak B. MD, David S. MD, Adolph J. MD, Peter MPH, Kyle MPH, Stefano A. MD, Henry D. MD, Emil MD, Rebecca L. MD, Stavros G. MD, Siraj A. MD, Alexander P. MD, Craig J. MD,